Relief Therapeutics Holding SA announced that it has entered into a share subscription agreement to issue shares for the gross proceeds of CHF 50 million on February 28, 2024. The transaction will include participation from returning investors, GEM Global Yield Fund, L.P., a fund managed by, Global Emerging Markets and new investor, GEM Yield Bahamas Limited.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1.25 CHF | -6.72% | -4.58% | -37.19% |
Mar. 22 | Sector Update: Health Care Stocks Steady Pre-Bell Friday | MT |
Mar. 22 | Sector Update: Health Care | MT |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-37.19% | 17.82M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- RLF Stock
- News Relief Therapeutics Holding SA
- Relief Therapeutics Holding SA announced that it expects to receive CHF 50 million in funding from Global Emerging Markets and another investor